ClearFlow
Irvine
About ClearFlow
ClearFlow is a medical device company developing technologies to solve clinical problems associated with obstructed catheters. The company's platform of catheter systems enables caregivers to actively clear internal obstructions to ensure these critical tubes perform optimally. The company’s lead product, the PleuraFlow, Active Clearance Technology, (ACT) System, was developed by cardiothoracic surgeons to solve the problem of chest tube failure by clot obstruction allowing doctors to manage the bleeding and clogging in a safer fashion. By enabling improved postoperative blood evacuation, surgeons are able to utilize minimally invasive drainage tubes, decreasing the surgical footprint, and potentially increasing patient comfort. The company has a pipeline of products based on its proprietary tube clearance technologies to resolve catheter clogging in other medical market segments, including urinary catheters, gastrointestinal catheters, and wound drainage. It was founded in 2007 and headquartered in Irvine, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $39.7M
- Last round: Series Unknown (May 2019)
- Website: clearflow.com
- Phone: (714) 916-5010
Industries & Categories
Health Care, Incubators, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/clearflow-59238 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.